+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Ulcerative Colitis Market by Therapy Type (Aminosalicylates, Biologics, Corticosteroids), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Route of Administration, Line Of Therapy, Patient Type, Disease Severity - Global Forecast 2025-2030- Product Image
Ulcerative Colitis Market by Therapy Type (Aminosalicylates, Biologics, Corticosteroids), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Route of Administration, Line Of Therapy, Patient Type, Disease Severity - Global Forecast 2025-2030- Product Image
Sale

Ulcerative Colitis Market by Therapy Type (Aminosalicylates, Biologics, Corticosteroids), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Route of Administration, Line Of Therapy, Patient Type, Disease Severity - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4985922
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Ulcerative Colitis Market is experiencing accelerated transformation driven by innovation in treatment modalities, evolving patient needs, and a dynamic regulatory landscape. Senior leaders face complex decisions as care paradigms shift and novel solutions alter the commercial landscape.

Market Snapshot: Ulcerative Colitis Market Growth and Trends

The ulcerative colitis market expanded from USD 8.14 billion in 2024 to USD 8.93 billion in 2025. This sector is projected to maintain robust growth with a compound annual growth rate of 9.44%, reaching a market value of USD 14.00 billion by 2030. Rising patient populations, new biologic therapies, and adaptive reimbursement models are influencing prescribing trends. Stakeholders are leveraging digital diagnostics and shifting supply chain strategies to respond to increasing demand for specialized care.

Scope & Segmentation

This analysis provides targeted insights across critical segments, regional dynamics, and the technologies shaping the ulcerative colitis market:

  • Therapy Types: Aminosalicylates, Biologics – Anti Integrins, IL Inhibitors, TNF Inhibitors, Corticosteroids, Immunomodulators, Small Molecule Drugs
  • Distribution Channels: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
  • Routes of Administration: Injectable (Intravenous, Subcutaneous), Oral
  • Line of Therapy: First Line, Second Line, Third Line and Beyond
  • Patient Types: Adult, Pediatric
  • Disease Severity: Mild, Moderate, Severe
  • Geographic Coverage: Americas (United States including California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Key Companies: AbbVie Inc., Janssen Biotech, Inc., Takeda Pharmaceutical Company Limited, Pfizer Inc., Celltrion, Inc., Samsung Bioepis Co., Ltd., Sandoz International GmbH, Fresenius Kabi AG, Viatris Inc., Apotex Inc.

Key Takeaways for Senior Decision Makers

  • Advanced biologics and small molecule drugs are driving a shift toward tailored treatment regimens, expanding options for moderate to severe cases.
  • Integration of digital health platforms and artificial intelligence is enhancing remote patient monitoring, adherence tracking, and diagnostic precision.
  • Strategic partnerships, acquisitions, and cross-sector collaborations are accelerating pipeline development and strengthening competitive positioning.
  • Patient stratification and targeted interventions support improved efficacy, while regional disparities in reimbursement and access are shaping market participation.
  • Pediatric patient populations and disease severity segmentation are fueling research into safety standards and individualized care protocols.
  • The growing emphasis on real-world evidence and value-based care is influencing payer decisions and fostering new contracting models.

Impact of 2025 United States Tariffs

Recent US tariff applications have increased costs throughout the active pharmaceutical ingredient supply chain for ulcerative colitis therapeutics. Manufacturers are adapting by diversifying sourcing, investing in regional production, and renegotiating contracts. Biosimilar entry has accelerated as payers intensify focus on cost containment, prompting companies to prioritize differentiated clinical and economic value as they navigate shifting procurement and alliance strategies.

Methodology & Data Sources

Findings are grounded in a rigorous multimodal research process, including interviews with key stakeholders, triangulation of secondary sources such as clinical trials and peer-reviewed journals, and expert validation panels. This integrated approach ensures accuracy and relevance of market insights, underpinned by strict adherence to confidentiality and quality standards.

Why This Report Matters

  • Offers a comprehensive framework for decision makers to evaluate emerging therapeutic innovations and market access environments in ulcerative colitis care.
  • Empowers business leaders to identify operational risks and strategic opportunities arising from evolving distribution channel preferences and regulatory trends.
  • Delivers actionable intelligence to align investment, commercialization, and partnership strategies amid increasing competition and complexity in global markets.

Conclusion

Ongoing advancements in ulcerative colitis treatment modalities, patient engagement, and regional policy responses create new avenues for strategic growth. Leveraging these research findings enables informed planning and more robust positioning in a rapidly evolving marketplace.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of fecal microbiota transplantation protocols in refractory ulcerative colitis management
5.2. Adoption of subcutaneously administered small molecules to improve patient adherence in ulcerative colitis therapy
5.3. Growing use of therapeutic drug monitoring to optimize biologic dosing in ulcerative colitis treatment
5.4. Development of gut-selective Janus kinase inhibitors for targeted inflammatory control in ulcerative colitis
5.5. Emergence of personalized therapeutic algorithms using multiomics biomarkers for ulcerative colitis stratification
5.6. Rising investment in digital health platforms for remote monitoring of ulcerative colitis disease activity
5.7. Expansion of biosimilar infliximab and adalimumab products driving cost competition in ulcerative colitis care
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Ulcerative Colitis Market, by Therapy Type
8.1. Introduction
8.2. Aminosalicylates
8.3. Biologics
8.3.1. Anti Integrins
8.3.2. IL Inhibitors
8.3.3. TNF Inhibitors
8.4. Corticosteroids
8.5. Immunomodulators
8.6. Small Molecule Drugs
9. Ulcerative Colitis Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacy
9.3. Online Pharmacy
9.4. Retail Pharmacy
10. Ulcerative Colitis Market, by Route of Administration
10.1. Introduction
10.2. Injectable
10.2.1. Intravenous
10.2.2. Subcutaneous
10.3. Oral
11. Ulcerative Colitis Market, by Line Of Therapy
11.1. Introduction
11.2. First Line
11.3. Second Line
11.4. Third Line And Beyond
12. Ulcerative Colitis Market, by Patient Type
12.1. Introduction
12.2. Adult
12.3. Pediatric
13. Ulcerative Colitis Market, by Disease Severity
13.1. Introduction
13.2. Mild
13.3. Moderate
13.4. Severe
14. Americas Ulcerative Colitis Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Ulcerative Colitis Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Ulcerative Colitis Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. AbbVie Inc.
17.3.2. Janssen Biotech, Inc.
17.3.3. Takeda Pharmaceutical Company Limited
17.3.4. Pfizer Inc.
17.3.5. Celltrion, Inc.
17.3.6. Samsung Bioepis Co., Ltd.
17.3.7. Sandoz International GmbH
17.3.8. Fresenius Kabi AG
17.3.9. Viatris Inc.
17.3.10. Apotex Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. ULCERATIVE COLITIS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ULCERATIVE COLITIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY THERAPY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY THERAPY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY LINE OF THERAPY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY LINE OF THERAPY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY PATIENT TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY DISEASE SEVERITY, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY DISEASE SEVERITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ULCERATIVE COLITIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS ULCERATIVE COLITIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ULCERATIVE COLITIS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES ULCERATIVE COLITIS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ULCERATIVE COLITIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ULCERATIVE COLITIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC ULCERATIVE COLITIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC ULCERATIVE COLITIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ULCERATIVE COLITIS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. ULCERATIVE COLITIS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. ULCERATIVE COLITIS MARKET: RESEARCHAI
FIGURE 28. ULCERATIVE COLITIS MARKET: RESEARCHSTATISTICS
FIGURE 29. ULCERATIVE COLITIS MARKET: RESEARCHCONTACTS
FIGURE 30. ULCERATIVE COLITIS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ULCERATIVE COLITIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ULCERATIVE COLITIS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ULCERATIVE COLITIS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY AMINOSALICYLATES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY AMINOSALICYLATES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY BIOLOGICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY ANTI INTEGRINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY ANTI INTEGRINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY IL INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY IL INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY TNF INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY TNF INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY IMMUNOMODULATORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY IMMUNOMODULATORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY SMALL MOLECULE DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY SMALL MOLECULE DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY FIRST LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY FIRST LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY SECOND LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY SECOND LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY THIRD LINE AND BEYOND, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY THIRD LINE AND BEYOND, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY MILD, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY MILD, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY MODERATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY MODERATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY SEVERE, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY SEVERE, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS ULCERATIVE COLITIS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS ULCERATIVE COLITIS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS ULCERATIVE COLITIS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS ULCERATIVE COLITIS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS ULCERATIVE COLITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS ULCERATIVE COLITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS ULCERATIVE COLITIS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS ULCERATIVE COLITIS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS ULCERATIVE COLITIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS ULCERATIVE COLITIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS ULCERATIVE COLITIS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS ULCERATIVE COLITIS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS ULCERATIVE COLITIS MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS ULCERATIVE COLITIS MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS ULCERATIVE COLITIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS ULCERATIVE COLITIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES ULCERATIVE COLITIS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES ULCERATIVE COLITIS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES ULCERATIVE COLITIS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES ULCERATIVE COLITIS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES ULCERATIVE COLITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES ULCERATIVE COLITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES ULCERATIVE COLITIS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES ULCERATIVE COLITIS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES ULCERATIVE COLITIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES ULCERATIVE COLITIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES ULCERATIVE COLITIS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES ULCERATIVE COLITIS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES ULCERATIVE COLITIS MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES ULCERATIVE COLITIS MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES ULCERATIVE COLITIS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES ULCERATIVE COLITIS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 107. CANADA ULCERATIVE COLITIS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 108. CANADA ULCERATIVE COLITIS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 109. CANADA ULCERATIVE COLITIS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 110. CANADA ULCERATIVE COLITIS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 111. CANADA ULCERATIVE COLITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. CANADA ULCERATIVE COLITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. CANADA ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 114. CANADA ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 115. CANADA ULCERATIVE COLITIS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 116. CANADA ULCERATIVE COLITIS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 117. CANADA ULCERATIVE COLITIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 118. CANADA ULCERATIVE COLITIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 119. CANADA ULCERATIVE COLITIS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 120. CANADA ULCERATIVE COLITIS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 121. CANADA ULCERATIVE COLITIS MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 122. CANADA ULCERATIVE COLITIS MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 123. MEXICO ULCERATIVE COLITIS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 124. MEXICO ULCERATIVE COLITIS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 125. MEXICO ULCERATIVE COLITIS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 126. MEXICO ULCERATIVE COLITIS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 127. MEXICO ULCERATIVE COLITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 128. MEXICO ULCERATIVE COLITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 129. MEXICO ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 130. MEXICO ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 131. MEXICO ULCERATIVE COLITIS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 132. MEXICO ULCERATIVE COLITIS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 133. MEXICO ULCERATIVE COLITIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 134. MEXICO ULCERATIVE COLITIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 135. MEXICO ULCERATIVE COLITIS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 136. MEXICO ULCERATIVE COLITIS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 137. MEXICO ULCERATIVE COLITIS MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 138. MEXICO ULCERATIVE COLITIS MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL ULCERATIVE COLITIS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL ULCERATIVE COLITIS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL ULCERATIVE COLITIS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL ULCERATIVE COLITIS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL ULCERATIVE COLITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL ULCERATIVE COLITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL ULCERATIVE COLITIS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL ULCERATIVE COLITIS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL ULCERATIVE COLITIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL ULCERATIVE COLITIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL ULCERATIVE COLITIS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL ULCERATIVE COLITIS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL ULCERATIVE COLITIS MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL ULCERATIVE COLITIS MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA ULCERATIVE COLITIS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA ULCERATIVE COLITIS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA ULCERATIVE COLITIS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA ULCERATIVE COLITIS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA ULCERATIVE COLITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA ULCERATIVE COLITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA ULCERATIVE COLITIS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA ULCERATIVE COLITIS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA ULCERATIVE COLITIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA ULCERATIVE COLITIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA ULCERATIVE COLITIS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA ULCERATIVE COLITIS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA ULCERATIVE COLITIS MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA ULCERATIVE COLITIS MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA ULCERATIVE COLITIS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA ULCERATIVE COLITIS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA ULCERATIVE COLITIS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA ULCERATIVE COLITIS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA ULCERATIVE COLITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA ULCERATIVE COLITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA ULCERATIVE COLITIS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA ULCERATIVE COLITIS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA ULCERATIVE COLITIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA ULCERATIVE COLITIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA ULCERATIVE COLITIS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA ULCERATIVE COLITIS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA ULCERATIVE COLITIS MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA ULCERATIVE COLITIS MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA ULCERATIVE COLITIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA ULCERATIVE COLITIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM ULCERATIVE COLITIS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM ULCERATIVE COLITIS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM ULCERATIVE COLITIS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM ULCERATIVE COLITIS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM ULCERATIVE COLITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM ULCERATIVE COLITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM ULCERATIVE COLITIS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM ULCERATIVE COLITIS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM ULCERATIVE COLITIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM ULCERATIVE COLITIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM ULCERATIVE COLITIS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM ULCERATIVE COLITIS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM ULCERATIVE COLITIS MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM ULCERATIVE COLITIS MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 205. GERMANY ULCERATIVE COLITIS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 206. GERMANY ULCERATIVE COLITIS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 207. GERMANY ULCERATIVE COLITIS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 208. GERMANY ULCERATIVE COLITIS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 209. GERMANY ULCERATIVE COLITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. GERMANY ULCERATIVE COLITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. GERMANY ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 212. GERMANY ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 213. GERMANY ULCERATIVE COLITIS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 214. GERMANY ULCERATIVE COLITIS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 215. GERMANY ULCERATIVE COLITIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 216. GERMANY ULCERATIVE COLITIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 217. GERMANY ULCERATIVE COLITIS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 218. GERMANY ULCERATIVE COLITIS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 219. GERMANY ULCERATIVE COLITIS MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 220. GERMANY ULCERATIVE COLITIS MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 221. FRANCE ULCERATIVE COLITIS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 222. FRANCE ULCERATIVE COLITIS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 223. FRANCE ULCERATIVE COLITIS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 224. FRANCE ULCERATIVE COLITIS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 225. FRANCE ULCERATIVE COLITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 226. FRANCE ULCERATIVE COLITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 227. FRANCE ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 228. FRANCE ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 229. FRANCE ULCERATIVE COLITIS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 230. FRANCE ULCERATIVE COLITIS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 231. FRANCE ULCERATIVE COLITIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 232. FRANCE ULCERATIVE COLITIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 233. FRANCE ULCERATIVE COLITIS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 234. FRANCE ULCERATIVE COLITIS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 235. FRANCE ULCERATIVE COLITIS MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 236. FRANCE ULCERATIVE COLITIS MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA ULCERATIVE COLITIS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA ULCERATIVE COLITIS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA ULCERATIVE COLITIS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA ULCERATIVE COLITIS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA ULCERATIVE COLITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA ULCERATIVE COLITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA ULCERATIVE COLITIS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA ULCERATIVE COLITIS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA ULCERATIVE COLITIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA ULCERATIVE COLITIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA ULCERATIVE COLITIS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA ULCERATIVE COLITIS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA ULCERATIVE COLITIS MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA ULCERATIVE COLITIS MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 253. ITALY ULCERATIVE COLITIS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 254. ITALY ULCERATIVE COLITIS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 255. ITALY ULCERATIVE COLITIS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 256. ITALY ULCERATIVE COLITIS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 257. ITALY ULCERATIVE COLITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 258. ITALY ULCERATIVE COLITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 259. ITALY ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 260. ITALY ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 261. ITALY ULCERATIVE COLITIS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 262. ITALY ULCERATIVE COLITIS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 263. ITALY ULCERATIVE COLITIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 264. ITALY ULCERATIVE COLITIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 265. ITALY ULCERATIVE COLITIS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 266. ITALY ULCERATIVE COLITIS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 267. ITALY ULCERATIVE COLITIS MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 268. ITALY ULCERATIVE COLITIS MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 269. SPAIN ULCERATIVE COLITIS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 270. SPAIN ULCERATIVE COLITIS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 271. SPAIN ULCERATIVE COLITIS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 272. SPAIN ULCERATIVE COLITIS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 273. SPAIN ULCERATIVE COLITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 274. SPAIN ULCERATIVE COLITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 275. SPAIN ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 276. SPAIN ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 277. SPAIN ULCERATIVE COLITIS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 278. SPAIN ULCERATIVE COLITIS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 279. SPAIN ULCERATIVE COLITIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 280. SPAIN ULCERATIVE COLITIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 281. SPAIN ULCERATIVE COLITIS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 282. SPAIN ULCERATIVE COLITIS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 283. SPAIN ULCERATIVE COLITIS MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 284. SPAIN ULCERATIVE COLITIS MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES ULCERATIVE COLITIS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES ULCERATIVE COLITIS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES ULCERATIVE COLITIS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES ULCERATIVE COLITIS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES ULCERATIVE COLITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES ULCERATIVE COLITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES ULCERATIVE COLITIS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES ULCERATIVE COLITIS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES ULCERATIVE COLITIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES ULCERATIVE COLITIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES ULCERATIVE COLITIS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES ULCERATIVE COLITIS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 299. UNITED ARAB EMIRATES ULCERATIVE COLITIS MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 300. UNITED ARAB EMIRATES ULCERATIVE COLITIS MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA ULCERATIVE COLITIS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA ULCERATIVE COLITIS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA ULCERATIVE COLITIS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA ULCERATIVE COLITIS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA ULCERATIVE COLITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA ULCERATIVE COLITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA ULCERATIVE COLITIS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA ULCERATIVE COLITIS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA ULCERATIVE COLITIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 312. SAUDI ARABIA ULCERATIVE COLITIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA ULCERATIVE COLITIS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 314. SAUDI ARABIA ULCERATIVE COLITIS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA ULCERATIVE COLITIS MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 316. SAUDI ARABIA ULCERATIVE COLITIS MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA ULCERATIVE COLITIS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 318. SOUTH AFRICA ULCERATIVE COLITIS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA ULCERATIVE COLITIS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 320. SOUTH AFRICA ULCERATIVE COLITIS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA ULCERATIVE COLITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 322. SOUTH AFRICA ULCERATIVE COLITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 324. SOUTH AFRICA ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA ULCERATIVE COLITIS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 326. SOUTH AFRICA ULCERATIVE COLITIS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 327. SOUTH AFRICA ULCERATIVE COLITIS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 328. SOUTH AFRICA ULCERATIVE COLITIS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 329. SOUTH AFRICA ULCERATIVE COLITIS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 330. SOUTH AFRICA ULCERATIVE COLITIS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 331. SOUTH AFRICA ULCERATIVE COLITIS MARKET SIZE, BY DISEASE SEVERITY, 2018-2024 (USD MILLION)
TABLE 332. SOUTH AFRICA ULCERATIVE COLITIS MARKET SIZE, BY DISEASE SEVERITY, 2025-2030 (USD MILLION)
TABLE 333. DENMARK ULCERATIVE COLITIS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 334. DENMARK ULCERATIVE COLITIS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 335. DENMARK ULCERATIVE COLITIS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 336. DENMARK ULCERATIVE COLITIS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 337. DENMARK ULCERATIVE COLITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
T

Samples

Loading
LOADING...

Companies Mentioned

  • AbbVie Inc.
  • Janssen Biotech, Inc.
  • Takeda Pharmaceutical Company Limited
  • Pfizer Inc.
  • Celltrion, Inc.
  • Samsung Bioepis Co., Ltd.
  • Sandoz International GmbH
  • Fresenius Kabi AG
  • Viatris Inc.
  • Apotex Inc.

Table Information

Report AttributeDetails
No. of Pages191
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 8.93 Billion
Forecasted Market Value ( USD ) by 2030 $ 14 Billion
Compound Annual Growth Rate9.4%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Ulcerative Colitis Market Report by Type, Disease Type, Molecule Type, Drug Type, Route of Administration, Distribution Channel, and Region 2025-2033 - Product Image

Ulcerative Colitis Market Report by Type, Disease Type, Molecule Type, Drug Type, Route of Administration, Distribution Channel, and Region 2025-2033

  • Report
  • 134 Pages
  • Global
From
Ulcerative Colitis Therapeutics - Global Strategic Business Report - Product Image

Ulcerative Colitis Therapeutics - Global Strategic Business Report

  • Report
  • 181 Pages
  • Global
From
Ulcerative Colitis Market Report and Forecast 2025-2034 - Product Image

Ulcerative Colitis Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Ulcerative Colitis - Market Insight, Epidemiology, and Market Forecast - 2034 - Product Image

Ulcerative Colitis - Market Insight, Epidemiology, and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Ulcerative Colitis Drug Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type - Product Image

Ulcerative Colitis Drug Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type

  • Report
  • 99 Pages
  • Global
From

About the Ulcerative Colitis Drug Market

The Ulcerative Colitis Drug market is a subset of the Gastrointestinal Drugs market, which includes medications used to treat a variety of gastrointestinal disorders. Ulcerative Colitis Drugs are used to treat the chronic inflammatory bowel disease of the same name. These drugs are typically administered orally or intravenously, and can be used to reduce inflammation, improve symptoms, and induce and maintain remission. Commonly prescribed Ulcerative Colitis Drugs include aminosalicylates, corticosteroids, immunomodulators, and biologics. The Ulcerative Colitis Drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include AbbVie, Pfizer, Takeda, Janssen, and UCB. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.